A SAFE is a startup fundraising contract that converts to equity later instead of paying investors back in cash. It carries no interest rate and no maturity date, and it only becomes stock once a company raises a priced round, gets acquired, or dissolves. Y Combinator introduced the format in 2013 and still publishes the templates most seed-stage deals use today.
What Is a SAFE, and Why Do Founders Use It?
A SAFE lets a founder take a check now and defer the hardest question in a seed round — what the company is worth — until a later priced financing sets that price for everyone at once.
The appeal is speed and cost. A SAFE is typically a handful of pages, signed without the legal back-and-forth a priced equity round involves. Unlike a convertible note, it is not debt: there's nothing accruing interest, nothing that has to be repaid if a priced round never happens, and nothing that shows up on the balance sheet as a liability.
That simplicity is also the tradeoff. A SAFE holder is not a shareholder and has no voting rights, no board seat, and no guaranteed conversion date. The instrument only pays off if a triggering event — a priced round, an acquisition, or a dissolution — actually happens.
What Are the Three Standard SAFE Structures?
For US companies, YC's SAFE templates come in three standard forms, each trading off investor protection differently.
- Valuation cap, no discount: investors convert at whichever is lower — the cap or the priced round's valuation — capping how much their stake gets diluted by a high future price.
- Discount, no valuation cap: investors convert at a fixed percentage below the price the priced round sets, with no ceiling on the company's eventual valuation.
- "Uncapped MFN," no cap or discount: investors get neither term upfront but are guaranteed the best terms given to any later SAFE holder in the same round, through a most-favored-nation clause.
YC also publishes a fourth, non-US variant — valuation cap, no discount — built for companies incorporated in Canada, the Cayman Islands, or Singapore.
How Does a SAFE Actually Convert to Equity?
Under the post-money version of the template, which YC moved to as its default in 2018, a SAFE converts before new investors' money is counted, but after every other outstanding SAFE from the same round is counted.
YC describes the mechanic directly: a post-money SAFE converts "after (post) all the safe money is accounted for — which is its own round now — but still before (pre) the new money in the priced round that converts and dilutes the safes (usually the Series A, but sometimes Series Seed)."
The practical effect is that a founder can calculate, at the moment each SAFE is signed, exactly what percentage of the company that check will eventually cost — something the earlier, pre-money SAFE format could not guarantee, since the total dilution depended on how many more SAFEs got stacked on top before the priced round.
What Legal Requirements Apply After a SAFE Closes?
A SAFE is still a securities sale, and most rounds rely on the same federal exemption a priced equity round would use: Rule 506(b) of Regulation D.
That exemption lets a company raise from an unlimited number of accredited investors, plus up to 35 non-accredited investors who have enough financial sophistication to evaluate the deal — without registering the offering with the SEC. In exchange, the company can't publicly advertise or solicit the round, and any information shared with accredited investors has to be made available to non-accredited investors too.
The paperwork obligation that survives the close: a Form D notice filed with the SEC within 15 days of the first sale of securities in the offering, on top of whatever notice filings and fees the relevant state requires.
SAFE vs. Convertible Note — What's the Real Difference?
A convertible note is debt: it accrues interest, carries a maturity date, and — if the company never raises a priced round or gets acquired before that date — can come due for repayment. A SAFE strips all three of those features out, at the cost of giving the investor a debt instrument's legal claim if things go wrong.
Most cap-table platforms now support both instruments side by side rather than forcing a choice up front. Carta, for instance, lets founders issue YC's post-money SAFE, Carta's own pre-money or post-money version, or a custom SAFE negotiated with a specific investor or law firm — alongside its convertible note tools.
The choice mostly comes down to what investors will sign. Angel and pre-seed rounds lean SAFE; some institutional seed investors still prefer the creditor protections a note provides, particularly outside the US startup hubs where the SAFE format is less standardized.
Frequently Asked Questions
Does a SAFE pay interest like a loan?
No. A SAFE is not debt, so it carries no interest rate and no repayment obligation — the only way an investor gets money or equity back is if a triggering event, like a priced round or acquisition, actually occurs.
What happens if a startup never raises a priced round?
The SAFE simply doesn't convert. Most templates include change-of-control and dissolution provisions that pay SAFE holders out of any sale or wind-down proceeds, but there's no forced repayment date the way a note would have.
Is a SAFE holder a shareholder right away?
No. A SAFE holder has no voting rights, no board seat, and no shares until the instrument converts at a triggering event — legally, they hold a contractual right to future stock, not stock itself.
What does a most-favored-nation clause do?
An MFN clause lets an investor who signed an uncapped, no-discount SAFE upgrade to the cap or discount given to any later investor in the same round, so early money isn't stuck with worse terms than money that came in afterward.
Does closing a SAFE round trigger any SEC paperwork?
Yes. Because a SAFE is a securities sale under Rule 506(b), the company generally has to file a Form D notice with the SEC within 15 days of the first sale, in addition to any state-level notice filings.
For more context, read Palantir: The AI Software Growth Record, Documented.
For more context, read mistral ai review.
For more context, read anduril valuation.